RMC-4627 potently inhibits 4E-BP1 phosphorylation in B-ALL cells in vitro at concentrations approximately 8-fold lower than an investigational TOR-KI (MLN0128, also known as TAK-228 or sapanasertib). This evidence concerns the gene EIF4EBP1 and acute lymphoblastic leukemia.